HUP9902550A2 - Methods of alleviating neuropathic pain using prosaposin-derived peptides - Google Patents
Methods of alleviating neuropathic pain using prosaposin-derived peptidesInfo
- Publication number
- HUP9902550A2 HUP9902550A2 HU9902550A HUP9902550A HUP9902550A2 HU P9902550 A2 HUP9902550 A2 HU P9902550A2 HU 9902550 A HU9902550 A HU 9902550A HU P9902550 A HUP9902550 A HU P9902550A HU P9902550 A2 HUP9902550 A2 HU P9902550A2
- Authority
- HU
- Hungary
- Prior art keywords
- prosaposin
- neuropathic pain
- methods
- derived peptides
- alleviating neuropathic
- Prior art date
Links
- 102100036197 Prosaposin Human genes 0.000 title abstract 3
- 101710152403 Prosaposin Proteins 0.000 title abstract 3
- 208000004296 neuralgia Diseases 0.000 title abstract 2
- 208000021722 neuropathic pain Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A prosaposin-derived peptide having from about 14-50 amino acids and including the sequence (A), is claimed: Thr-Xaa-Leu-Ile-Asp-Asn-Asn-Ala-Thr-Glu-Glu-Ile-Leu-Tyr (A); Xaa = D-alanine. Also claimed is a method of alleviating or preventing neuropathic pain in a subject, comprising administering an effective amount of an active fragment of prosaposin to the subject.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902550A HUP9902550A3 (en) | 1997-03-05 | 1997-03-05 | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902550A HUP9902550A3 (en) | 1997-03-05 | 1997-03-05 | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9902550A2 true HUP9902550A2 (en) | 1999-12-28 |
HUP9902550A3 HUP9902550A3 (en) | 2001-09-28 |
Family
ID=89998879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9902550A HUP9902550A3 (en) | 1997-03-05 | 1997-03-05 | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP9902550A3 (en) |
-
1997
- 1997-03-05 HU HU9902550A patent/HUP9902550A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP9902550A3 (en) | 2001-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69736712D1 (en) | PROCESS FOR REDUCING NEUROPATHIC PAIN RELATED TO PROSAPOSIN-RELATED PEPTIDES | |
EP2258383A3 (en) | Antigenic peptides derived from telomerase | |
HUP9903530A2 (en) | Antiangiogenic peptides derived from plasminogen | |
IL205233A0 (en) | A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof | |
ATE318915T1 (en) | GENE FAMILY OF APOPTOSIS-RELATED PEPTIDES, PEPTIDES ENCODED THEREFROM AND METHOD FOR THE PRODUCTION THEREOF | |
HK1021824A1 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
WO1998055508A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
CA2111645A1 (en) | Fibrinogen fragment e peptides and antibodies thereto | |
WO1996028470A3 (en) | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis | |
WO2000075173A3 (en) | Peptide fragments of colostrinin | |
NZ333606A (en) | Isolated peptides derived from MAGE-2 | |
CA2303395A1 (en) | Treatment of obesity | |
NZ294397A (en) | Cloning of an insulin-dependent membrane aminopeptidase designated GTVap from GLUT-4 vesicles | |
WO2004014937A3 (en) | Thrombin peptide derivatives | |
EP1006126A3 (en) | Osteogenic peptides | |
AU5090898A (en) | Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides | |
AU8811298A (en) | Novel peptides and polypeptides useful for regenerating the nervous system | |
EP0759772A4 (en) | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent | |
HUP9902550A2 (en) | Methods of alleviating neuropathic pain using prosaposin-derived peptides | |
WO1996003122A3 (en) | Use of gabapentin in the treatment of anxiety and panic | |
EP0837074A3 (en) | Biologically active fibronectin fragment as cancer metastasis inhibitor | |
IL129368A0 (en) | Immunogenic TLP composition | |
AU3433384A (en) | Pharmakologisch aktive peptide | |
CA2259640A1 (en) | Human glycine transporter | |
GB2357507A (en) | Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |